Rationale: Gaucher disease (GD) is a rare hereditary lysosomal storage disorder disease progression and inappropriate treatment. However, not all patients with GD receive timely diagnosis and treatment. Patient concerns: Early diagnosis is important for initiating proper treatment and preventing complications. Diagnoses: Two patients were diagnosed as GD in this study. Interventions and outcomes: These 2 patients received the imiglucerase enzyme replacement and symptoms significantly improved by the follow-up. Lessons: Herein, we report 2 patients with a delayed diagnosis of GD to increase awareness and improve education regarding rare diseases. However, noninvasive β-glucocerebrosidase activity or GBA gene testing had not been done before bone marrow aspiration, which are the noninvasive and reliable tests that indicate the diagnosis of GD.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: